Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial disease
- PMID: 17062650
- DOI: 10.1152/physiolgenomics.00204.2006
Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial disease
Abstract
Heart disease is the major cause of death in diabetes, a disorder characterized by chronic hyperglycemia and cardiovascular complications. Diabetic cardiomyopathy (DCM) is increasingly recognized as a major contributor to diastolic dysfunction and heart failure in diabetes, but its molecular basis has remained obscure, in part because of its multifactorial origins. Here we employed comparative transcriptomic methods with quantitative verification of selected transcripts by reverse transcriptase quantitative PCR to characterize the molecular basis of DCM in rats with streptozotocin-induced diabetes of 16-wk duration. Diabetes caused left ventricular disease that was accompanied by significant changes in the expression of 1,614 genes, 749 of which had functions assignable by Gene Ontology classification. Genes corresponding to proteins expressed in mitochondria accounted for a disproportionate number of those whose expression was significantly modified in DCM, consistent with the idea that the mitochondrion is a key target of the pathogenic processes that cause myocardial disease in diabetes. Diabetes also induced global perturbations in the expression of genes regulating cardiac fatty acid metabolism, whose dysfunction is likely to play a key role in the promotion of oxidative stress, thereby contributing to the pathogenesis of diabetic myocardial disease. In particular, these data point to impaired regulation of mitochondrial beta-oxidation as central in the mechanisms that generate DCM pathogenesis. This study provides a comprehensive molecular snapshot of the processes leading to myocardial disease in diabetes.
Similar articles
-
Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.Circulation. 2005 Apr 26;111(16):2073-85. doi: 10.1161/01.CIR.0000162472.52990.36. Circulation. 2005. PMID: 15851615
-
Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.Physiol Genomics. 2006 Aug 16;26(3):192-201. doi: 10.1152/physiolgenomics.00196.2005. Epub 2006 May 9. Physiol Genomics. 2006. PMID: 16684804
-
[Expression of energy metabolism-related genes in myocardial tissues of rats with diabetic cardiomyopathy].Di Yi Jun Yi Da Xue Xue Bao. 2002 Nov;22(11):1009-10. Di Yi Jun Yi Da Xue Xue Bao. 2002. PMID: 12433633 Chinese.
-
Oxidative stress: a key contributor to diabetic cardiomyopathy.Can J Physiol Pharmacol. 2010 Mar;88(3):233-40. doi: 10.1139/Y10-016. Can J Physiol Pharmacol. 2010. PMID: 20393588 Review.
-
Mitochondrial oxidative stress and dysfunction in myocardial remodelling.Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Cardiovasc Res. 2009. PMID: 18854381 Review.
Cited by
-
Diabetes and Heart Failure: Multi-Omics Approaches.Front Physiol. 2021 Aug 6;12:705424. doi: 10.3389/fphys.2021.705424. eCollection 2021. Front Physiol. 2021. PMID: 34421642 Free PMC article. Review.
-
Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.Cardiovasc Diabetol. 2017 Dec 4;16(1):155. doi: 10.1186/s12933-017-0638-z. Cardiovasc Diabetol. 2017. PMID: 29202762 Free PMC article. Review.
-
Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity.J Mol Cell Cardiol. 2010 Apr;48(4):582-90. doi: 10.1016/j.yjmcc.2009.10.033. Epub 2009 Nov 11. J Mol Cell Cardiol. 2010. PMID: 19913546 Free PMC article.
-
Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats.Cardiovasc Diabetol. 2013 Aug 28;12:123. doi: 10.1186/1475-2840-12-123. Cardiovasc Diabetol. 2013. PMID: 23981320 Free PMC article.
-
Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy.Pflugers Arch. 2022 Jan;474(1):33-61. doi: 10.1007/s00424-021-02650-y. Epub 2022 Jan 3. Pflugers Arch. 2022. PMID: 34978597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases